Executive Summary
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Hepatitis B Treatment Market by Type (Therapeutics and Vaccines), By End-User (Male and Female) for the regions (North America, Europe, Asia—Pacific and ROW) and By Country (U.S., Canada, U.K., Germany, France, China, India, Japan).
Over the recent years, the global Hepatitis B Treatment industry has been driven by the increasing number of patients diagnosed with Chronic Hepatitis B which results in severe complications, rising awareness about the consequences of viral infection, rigorous efforts to eliminate the viral infection, improving surveillance and diagnostic facilities, significant number of drugs in pipeline with better efficacy coupled with emerging vaccines with lower dosage and better effectiveness. Globally, the growth in Hepatitis B Treatment market is driven by backed by growing middle class population group demanding better drugs to improve lifestyle.
According to Azoth Analytics research report "Global Hepatitis B Virus [HBV] Treatment Market - Analysis By Type (Therapeutics, Vaccine), By End User (Male, Female) - By Region, By Country: Opportunities and Forecast (2017-2022) - By Region (N. America, Europe, APAC, ROW), By Country (US, Canada, UK, Germany, France, China, India, Japan)", global market is projected to display a growth represented by a CAGR of 5.30% by value during 2017 - 2022, chiefly driven by increase in healthcare spending and improving access to diagnosis for Chronic Hepatitis B, increasing risk of severe complications due to Hepatitis B virus.
Among the type of treatment, therapeutics accounts for the major market share and anticipated to witness significant growth rate during the forecast period. Among the regions, Asia Pacific is predicted to advance at the highest rate, mainly driven by large population suffering with chronic Hepatitis B virus with unfulfilled need, improving access to healthcare, changing lifestyle and expanding middle class income group.
The report titled, "Global Hepatitis B Virus [HBV] Treatment Market - Analysis By Type (Therapeutics, Vaccine), By End User (Male, Female) - By Region, By Country: Opportunities and Forecast (2017-2022) - By Region (N. America, Europe, APAC, ROW), By Country (US, Canada, UK, Germany, France, China, India, Japan)" has covered and analysed the potential of Hepatitis B Treatment Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global Hepatitis B Treatment market. Additionally, the report also highlights market entry strategies for various companies across the globe.
Scope of the Report
Global Market (Actual Period: 2012-2016, Forecast Period: 2017-2022)
• Global Hepatitis B Treatment Market
• Analysis By Type (Therapeutics and Vaccines)
• Analysis By End-User (Male and Female)
Regional Markets - North America, Europe, APAC, ROW (Actual Period: 2012-2016, Forecast Period: 2017-2022)
• By Type (Therapeutics and Vaccines)
• By End-User (Male and Female)
Country Analysis - United States, Canada, United Kingdom, Germany, France, China, India, Japan (Actual Period: 2012-2016, Forecast Period: 2017-2022)
• By Type (Therapeutics and Vaccines)
• By End-User (Male and Female)
Other Report Highlights
• Market Dynamics - Trends, Drivers, Challenges, Policy and Regulation
• Company Analysis - Merck and Co; Gilead Sciences; Novartis AG; GlaxoSmithKline, plc; Hoffmann- La Roche; Bristol-Myers Squibb
Customization of the Report
The report could be customized according to the client's specific research requirements. No additional cost will be required to pay for limited additional research.
Table of Contents
1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
4. Hepatitis B Treatment Market: Product Outlook
5. Global Hepatitis B Treatment Market: Growth and Forecast
5.1. Global Hepatitis B Treatment Market, By Value (2012-2016)
5.2. Global Hepatitis B Treatment Market, By Value (2017-2022)
5.3. Global Hepatitis B Treatment Market - By Type, By Value
5.3.1. Global Hepatitis B Treatment Market, By Value, % (2016)
5.3.2. Global Hepatitis B Treatment Market, By Value, % (Forecast 2022F)
5.4. Global Hepatitis B Treatment Market, By Type, By Value (2012-2022)
5.4.1. Therapeutics, By Value (2012-2022)
5.4.2. Vaccines, By Value (2012-2022)
5.5. Global Hepatitis B Treatment Market, By End-User, By Value (2012-2022)
5.5.1. Male, By Value (2012-2022)
5.5.2. Female, By Value (2012-2022)
6. North America Hepatitis B Treatment Market: Growth and Forecast
6.1. North America Hepatitis B Treatment Market, By Value (2012-2016)
6.2. North America Hepatitis B Treatment Market, By Value (2017-2022)
6.3. North America Hepatitis B Treatment Market - By Type, By Value
6.3.1. North America Hepatitis B Treatment Market, By Value, % (2016)
6.3.2. North America Hepatitis B Treatment Market, By Value, % (Forecast 2022F)
6.4. North America Hepatitis B Treatment Market, By Type, By Value (2012-2022)
6.4.1. Therapeutics, By Value (2012-2022)
6.4.2. Vaccines, By Value (2012-2022)
6.5. North America Hepatitis B Treatment Market, By End-User, By Value (2012-2022)
6.5.1. Male, By Value (2012-2022)
6.5.2. Female, By Value (2012-2022)
6.6. North America Hepatitis B Treatment Market: Country Analysis (U.S., Canada)
6.6.1. North America Hepatitis B Treatment Market, Country Share, 2016 (% of Total)
6.6.2. North America Hepatitis B Treatment Market, Country Share, 2022 (% of Total)
6.7. U.S. Hepatitis B Treatment Market: Growth and Forecast
6.7.1. U.S. Hepatitis B Treatment Market, By Value (2012-2016)
6.7.2. U.S. Hepatitis B Treatment Market, By Value (2017-2022)
6.8. U.S. Hepatitis B Treatment Market - By Type, By Value
6.8.1. Therapeutics, By Value (2012-2022)
6.8.2. Vaccines, By Value (2012-2022)
6.9. U.S. Hepatitis B Treatment Market - By End-User, By Value
6.9.1. Male, By Value (2012-2022)
6.9.2. Female, By Value (2012-2022)
6.10. Canada Hepatitis B Treatment Market: Growth and Forecast
6.10.1. Canada Hepatitis B Treatment Market, By Value (2012-2016)
6.10.2. Canada Hepatitis B Treatment Market, By Value (2017-2022)
6.11. Canada Hepatitis B Treatment Market - By Type, By Value
6.11.1. Therapeutics, By Value (2012-2022)
6.11.2. Vaccines, By Value (2012-2022)
6.12. Canada Hepatitis B Treatment Market - By End-User, By Value
6.12.1. Male, By Value (2012-2022)
6.12.2. Female, By Value (2012-2022)
7. Europe Hepatitis B Treatment Market: Growth and Forecast
7.1. Europe Hepatitis B Treatment Market, By Value (2012-2016)
7.2. Europe Hepatitis B Treatment Market, By Value (2017-2022)
7.3. Europe Hepatitis B Treatment Market - By Type, By Value
7.3.1. Europe Hepatitis B Treatment Market, By Value, % (2016)
7.3.2. Europe Hepatitis B Treatment Market, By Value, % (Forecast 2022F)
7.4. Europe Hepatitis B Treatment Market, By Type, By Value (2012-2022)
7.4.1. Therapeutics, By Value (2012-2022)
7.4.2. Vaccines, By Value (2012-2022)
7.5. Europe Hepatitis B Treatment Market, By End-User, By Value (2012-2022)
7.5.1. Male, By Value (2012-2022)
7.5.2. Female, By Value (2012-2022)
7.6. Euope Hepatitis B Treatment Market: Country Analysis (U.K., Germany, France)
7.6.1. Europe Hepatitis B Treatment Market, Country Share, 2016 (% of Total)
7.6.2. Europe Hepatitis B Treatment Market, Country Share, 2022 (% of Total)
7.7. U.K. Hepatitis B Treatment Market: Growth and Forecast
7.7.1. U.K. Hepatitis B Treatment Market, By Value (2012-2016)
7.7.2. U.K. Hepatitis B Treatment Market, By Value (2017-2022)
7.8. U.K. Hepatitis B Treatment Market - By Type, By Value
7.8.1. Therapeutics, By Value (2012-2022)
7.8.2. Vaccines, By Value (2012-2022)
7.9. U.K. Hepatitis B Treatment Market - By End-User, By Value
7.9.1. Male, By Value (2012-2022)
7.9.2. Female, By Value (2012-2022)
7.10. Germany Hepatitis B Treatment Market: Growth and Forecast
7.10.1. Germany Hepatitis B Treatment Market, By Value (2012-2016)
7.10.2. Germany Hepatitis B Treatment Market, By Value (2017-2022)
7.11. Germany Hepatitis B Treatment Market - By Type, By Value
7.11.1. Therapeutics, By Value (2012-2022)
7.11.2. Vaccines, By Value (2012-2022)
7.12. Germany Hepatitis B Treatment Market - By End-User, By Value
7.12.1. Male, By Value (2012-2022)
7.12.2. Female, By Value (2012-2022)
7.13. France Hepatitis B Treatment Market: Growth and Forecast
7.13.1. France Hepatitis B Treatment Market, By Value (2012-2016)
7.13.2. France Hepatitis B Treatment Market, By Value (2017-2022)
7.14. France Hepatitis B Treatment Market - By Type, By Value
7.14.1. Therapeutics, By Value (2012-2022)
7.14.2. Vaccines, By Value (2012-2022)
7.15. France Hepatitis B Treatment Market - By End-User, By Value
7.15.1. Male, By Value (2012-2022)
7.15.2. Female, By Value (2012-2022)
8. Asia-Pacific Hepatitis B Treatment Market: Growth and Forecast
8.1. Asia-Pacific Hepatitis B Treatment Market, By Value (2012-2016)
8.2. Asia-Pacific Hepatitis B Treatment Market, By Value (2017-2022)
8.3. Asia-Pacific Hepatitis B Treatment Market - By Type, By Value
8.3.1. Asia-Pacific Hepatitis B Treatment Market, By Value, % (2016)
8.3.2. Asia-Pacific Hepatitis B Treatment Market, By Value, % (Forecast 2022F)
8.4. Asia-Pacific Hepatitis B Treatment Market, By Type, By Value (2012-2022)
8.4.1. Therapeutics, By Value (2012-2022)
8.4.2. Vaccines, By Value (2012-2022)
8.5. Asia-Pacific Hepatitis B Treatment Market, By End-User, By Value (2012-2022)
8.5.1. Male, By Value (2012-2022)
8.5.2. Female, By Value (2012-2022)
8.6. Asia-Pacific Hepatitis B Treatment Market: Country Analysis (Japan, China, India)
8.6.1. Asia-Pacific Hepatitis B Treatment Market, Country Share, 2016 (% of Total)
8.6.2. Asia-Pacific Hepatitis B Treatment Market, Country Share, 2022 (% of Total)
8.7. Japan Hepatitis B Treatment Market: Growth and Forecast
8.7.1. Japan Hepatitis B Treatment Market, By Value (2012-2016)
8.7.2. Japan Hepatitis B Treatment Market, By Value (2017-2022)
8.8. Japan Hepatitis B Treatment Market - By Type, By Value
8.8.1. Therapeutics, By Value (2012-2022)
8.8.2. Vaccines, By Value (2012-2022)
8.9. Japan Hepatitis B Treatment Market - By End-User, By Value
8.9.1. Male, By Value (2012-2022)
8.9.2. Female, By Value (2012-2022)
8.10. China Hepatitis B Treatment Market: Growth and Forecast
8.10.1. China Hepatitis B Treatment Market, By Value (2012-2016)
8.10.2. China Hepatitis B Treatment Market, By Value (2017-2022)
8.11. China Hepatitis B Treatment Market - By Type, By Value
8.11.1. Therapeutics, By Value (2012-2022)
8.11.2. Vaccines, By Value (2012-2022)
8.12. China Hepatitis B Treatment Market - By End-User, By Value
8.12.1. Male, By Value (2012-2022)
8.12.2. Female, By Value (2012-2022)
8.13. India Hepatitis B Treatment Market: Growth and Forecast
8.13.1. India Hepatitis B Treatment Market, By Value (2012-2016)
8.13.2. India Hepatitis B Treatment Market, By Value (2017-2022)
8.14. India Hepatitis B Treatment Market - By Type, By Value
8.14.1. Therapeutics, By Value (2012-2022)
8.14.2. Vaccines, By Value (2012-2022)
8.15. India Hepatitis B Treatment Market - By End-User, By Value
8.15.1. Male, By Value (2012-2022)
8.15.2. Female, By Value (2012-2022)
9. ROW Hepatitis B Treatment Market: Growth and Forecast
9.1. ROW Hepatitis B Treatment Market, By Value (2012-2016)
9.2. ROW Hepatitis B Treatment Market, By Value (2017-2022)
10. Market Dynamics
10.1. Increasing prevalence of Liver diseases due to Hepatitis B
10.2. Increasing awareness about the Hepatitis B & HBV
10.3. Rising healthcare expenditure worldwide
11. Market Restraints
12. SWOT Analysis - Hepatitis B Treatment Market
13. Porter's Five Forces Analysis
14. Policy and Regulations
15. Global Hepatitis B Drugs Pipeline
16. Global Hepatitis B Treatment Market - Competitive Landscape
17. Company Profiles
17.1. Merck and Co
17.2. Gilead Sciences
17.3. Novartis AG
17.4. GlaxoSmithKline, plc
17.5. F.Hoffmann- La Roche
17.6. Bristol-Myers Squibb
17.7. AbbVie Inc
The Water Treatment Plant Monitoring Service Market is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lands...
The Landfill Leachate Treatment Solutions Market is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscap...
The Food Waste Treatment Systems Market is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufa...
The Cancer Treatment Support Services Market is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
PPI
Euromonitor International's Industrial reports provide a 360 degree view of an industry. The Industrial market report offers a comprehensive guide to the size and shape of the Hairdressing and Beauty Treatment: ISIC 9302 market at a national level. It provides the latest retail sale...
Economic challenges towards the end of the review period have pushed consumers towards more budget friendly air treatment products. Heightened consumer budget consciousness is dampening demand for high-end air purifiers with advanced filtration systems, and premium feature-rich air conditioners. Ins...
The Research-grade AAV Virus Packaging Services Market is set to witness immense growth during the forecast period 2025-2032. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive la...
The Hidradenitis Suppurativa Treatment Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ...
Market Overview
The Asia Pacific Safety Valves Market is expected to witness substantial growth from 2024 to 2034, driven by increasing industrial activities and the rising demand for enhanced safety standards across key sectors. The market is projected to reach USD XX.XX billion by 203...
Market Overview
The Europe Safety Valves Market is projected to witness steady growth from 2024 to 2034, driven by rising demand across critical industries such as oil and gas, energy and power, and water treatment. With increased focus on safety and regulatory compliance, the market is...